neutral west nile virus nv vivo correct develop antibody response viral envelope e protein use random mutagenesi yeast surface display define individual contact reside newly genre monoclonal antibody domain iii strongly neutral local patch later face convalesc individual recon infect also detect editor one differ strain vitro show therapeutic efficacy mouse even admins single dose human version retain antigen specify avid neutral active postexposur trial protect wnvinduc mortal may therefore viable treatment option human supplementary inform online article doing contain mater avail author user 